MedTrace Logo

PET Enhanced CT Scan Performance in Cancer

NCT01881620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2024-11-18

Study results available
· View outcomes & findings →

Summary

Hypothesis:

The investigators would like to demonstrate that diagnosis performance of PET/CT scan without and with contrast agent (COMBI TEP), are equivalent or better than those of PET/ non enhanced CT scan (PET scan) associated with an enhanced CT scan. This research project is a pilot study given the few available data concerning this imaging exam reproducibility.

This study is a prospective single center study.

Conditions

  • Cancer Disease Progression

Interventions

DEVICE

COMBI TEP : PET / enhanced CT scan

diagnostic imaging exam

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • CAZEAU Anne Laure, MD · Institut Bergonié

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-19
Primary Completion
2012-07-19
Completion
2015-07-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881620 on ClinicalTrials.gov